Only abstract available here to general public. Thrombocytopenia is associated with IL-2 therapy. Melatonin found to block this effect when used in conjunction with IL-2 therapy. Alone, melatonin did not increase platelet levels. The proposed mechanism is an inhibition of macrophage mediated destruction of plateletes.